Latest Episodes
Advanced HCC: Patients not eligible for IO - What are the treatment options?
Prof. Dr James Harding, Medical Oncologist at Memorial Sloan Kettering Cancer Center and Prof. Dr Sammy Saab, Gastroenterologist and Transplant Hepatologist at the David...
Prostate cancer: PARP inhibitors. Part 2 - Combination therapy; US and EU perspectives
Dr Neal Shore, Uro-Oncologist and Chief Medical Officer for Genesis Care and Urology and Surgical Oncology in the United States and Dr Elena Castro,...
Prostate cancer: PARP inhibitors. Part 1 - PARPi monotherapy; US and EU perspectives
Dr Neal Shore, Uro-Oncologist and Chief Medical Officer for Genesis Care and Urology and Surgical Oncology in the United States and Dr Elena Castro,...
Endometrial carcinoma: Systemic therapies. Part 1 - The physicians' perspective
Join world-renowned gynaecological oncology experts Dr Domenica “Ketta” Lorusso and Dr Mansoor Mirza as they explore the changing landscape of systemic treatment in endometrial...
Lower GI cancer: Highlights from ASCO GI 2023 - Part 2
This episode, covers the highlights on colorectal cancer from ASCO GI 2023. Prof. Andrea Sartore-Bianchi (Niguada Cancer Center, Milan, Italy) and Prof. Shubham Pant...
Upper GI cancer Highlights from ASCO GI 2023 - Part 1
This episode, covers the highlights on gastroesophageal, gastric and gastroesophageal junction (GEJ) cancer from ASCO GI 2023. Dr Nataliya Uboha (University of Wisconsin, USA)...